Asymchem Laboratories (Tianjin) Co., Ltd.
002821
Rank in Stocks
#2511
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development... Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Share Price
$20.91
Market Cap
$7.57B
Change (1 day)
-8.26%
Change (1 year)
41.25%
Country
CN
Trade Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Category
Healthcare
Earnings for Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Earnings in Jun 2026 TTM: $175.62M
According to Asymchem Laboratories (Tianjin) Co., Ltd. latest financial reports the company's current earnings are $175.62M. In 2024 the company made an earning of $146.92M, a decrease compared to its 2023 earnings that were of $361.25M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Asymchem Laboratories (Tianjin) Co., Ltd. from 2011 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $175.62M | -4.48% |
| 2025 | $183.86M | 25.15% |
| 2024 | $146.92M | -59.33% |
| 2023 | $361.25M | -33.10% |
| 2022 | $540.01M | 187.71% |
| 2021 | $187.69M | 51.14% |
| 2020 | $124.18M | 38.67% |
| 2019 | $89.55M | 33.73% |
| 2018 | $66.96M | 3.22% |
| 2017 | $64.87M | 38.39% |
| 2016 | $46.88M | 52.55% |
| 2015 | $30.73M | 43.65% |
| 2014 | $21.39M | 28.73% |
| 2013 | $16.62M | 23.63% |
| 2012 | $13.44M | -5.39% |
| 2011 | $14.21M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $5.27B | 2,903.53% |
US
|
|
| $-3.09B | -1,857.74% |
US
|
|
| $-4.02B | -2,386.83% |
AU
|
|
| $3.01B | 1,611.46% |
BE
|
|
| $1.95B | 1,010.70% |
NL
|
